Dr. Hyman Scott, Medical Director
Bridge HIV CRS, San Francisco, CA, USA
Dr. Scott is the Medical Director for Clinical Research at Bridge HIV in the San Francisco Department of Public Health. He received his BA from Stanford University; MD from Yale School of Medicine; and MPH from the University of California, Berkeley. He completed his Internal Medicine residency, Chief Residency, Infectious Disease fellowship, and post-doctoral research training in the Traineeship for AIDS Prevention Studies at University of California, San Francisco (UCSF), where he is an Assistant Clinical Professor of Medicine.
His interest in HIV prevention research started during medical school after learning about the rising number of HIV infections in marginalized populations domestically and globally, and the need for new prevention options. He has a particular interest in the epidemiology of HIV-related racial and ethnic disparities among men who have sex with men (MSM), and interventions to reduce those disparities. He is currently the protocol co-chair of HVTN 119 and HVTN 129/HPTN 088. He most appreciates the collaborative opportunities and support within the HVTN for early stage investigators. In addition to conducting HIV vaccine and Pre-Exposure Prophylaxis (PrEP) studies at Bridge HIV, he is developing and testing technology-based HIV prevention interventions for MSM, including mobile and web apps, focused on sexual behavior risk reduction and uptake of HIV prevention interventions such as HIV testing and PrEP. Dr. Scott currently has a K23 award from the National Institute of Mental Health to develop and test a mobile app-based combination HIV intervention tool that incorporates home HIV self-testing, self-collection of samples for STI testing, and PrEP uptake among young Black MSM in the San Francisco Bay Area.